Why Realogy (RLGY) Stock Is Down Today

NEW YORK (TheStreet) -- Realogy (RLGY) was falling -11.7% to $37.67 Monday after posting a larger-than-expected loss for the first quarter.

For the first quarter Realogy posted a loss of -32 cents a share, missing the Capital IQ Consensus Estimate of a loss of -21 cents a share by 11 cents. Revenue grew 4.5% from the year-ago quarter to $1 billion. Analysts expected revenue of $1.1 billion for the quarter.

Looking to second quarter of 2014, Realogy expects homesale transaction volumes of between -2% to 2%.

"Realogy achieved homesale transaction volume growth of 10% year-over-year in the first quarter, which is at the midpoint of our prior guidance range," chairman and CEO Richard A. Smith said in a press release. "Our volume growth was driven by a 13% increase in average sales price that was partially offset by a 3% decline in transaction sides. We saw two opposing trends in the first quarter that caused an overall shift in Realogy's mix of business resulting in a higher average sale price and reduced transaction sides."

Must read: Warren Buffett's 10 Favorite Growth Stocks

SELL NOW: If you own any of the 900 stocks that TheStreet Quant Ratings has identified as a 'Sell'...you could potentially lose EVERYTHING in the next 6-12 months. Learn more.


Separately, TheStreet Ratings team rates REALOGY HOLDINGS CORP as a Sell with a ratings score of D. TheStreet Ratings Team has this to say about their recommendation:

"We rate REALOGY HOLDINGS CORP (RLGY) a SELL. This is driven by multiple weaknesses, which we believe should have a greater impact than any strengths, and could make it more difficult for investors to achieve positive results compared to most of the stocks we cover. The company's weaknesses can be seen in multiple areas, such as its generally high debt management risk and generally disappointing historical performance in the stock itself."

If you liked this article you might like

P&G's Director Problem Takes Center Stage in Battle With Activist Nelson Peltz

Zillow Sites Start Charging Fee for NYC Rental Listings, And One Big Broker Says No Thanks

A Famous Company You've Never Heard Of

Analysts' Actions -- Bristol-Myers, Merck, United Technologies and More

Bullish and Bearish Reversals for the Week